Covid-19 vaccine India update: PGI Rohtak to start phase-2 trial of Bharat Biotech's Covaxin

The phase 2 human clinical trial of Bharat Biotech's COVID-19 vaccine Covaxin at PGI Rohtak will involve 300 volunteers.Covaxin is one of the frontrunners in the race for a Covid-19 vaccine in India

from mint - News https://ift.tt/2R2kU2j
https://ift.tt/eA8V8J